https://www.selleckchem.com/products/GDC-0879.html
e. male, lung cancer, stage I, no symptoms); the corresponding discrimination for each outcome model had high AUCs of 0.807, 0.713, 0.709, 0.790, and 0.723, respectively. Generally these covariates increased the outcome risk by 10% across all models lung disease, dementia, diabetes; radiation treatment; hospital admission; pain; depression; transitional performance status; issues with appetite; or homecare. The model accurately predicted changing cancer risk for low performance status and severe symptoms over time. The model accura